Skip to main content
. Author manuscript; available in PMC: 2022 Oct 31.
Published in final edited form as: Pediatr Allergy Immunol. 2022 Mar;33(3):e13753. doi: 10.1111/pai.13753

TABLE 2.

Descriptive characteristics of study participants

Overall sample No child filaggrin mutation Yes child filaggrin mutationa
Sample size (N) 624 575 49
Continuous variables median (interquartile range) p-valueb
Breastmilk months 7.00 (2.00, 12.75) 7.00 (2.00, 12.63) 5.38 (1.52, 13.00) .86
Age of introduction of solid foods (months) 6.00 (5.00, 6.00) 6.00 (5.00, 6.00) 6.00 (4.00, 6.00) .73
Categorical variables n (%) p-valuec
Maternal diet index ≥median 312 (50) 281 (50) 31 (63) .07
Gestational smoking 56 (9) 50 (9) 6 (12) .43
Nulliparous 314 (50) 286 (50) 28 (57) .37
Maternal history of asthma 101 (16) 91 (16) 10 (20) .42
Mode of delivery—vaginal 491 (79) 453 (79) 38 (78) .86
Child’s race/ethnicity .67
Non-Hispanic White 323 (52) 293 (51) 30 (61)
Non-Hispanic Black 77 (12) 72 (13) 5 (10)
Hispanic 147 (24) 138 (24) 9 (18)
Otherd 77 (12) 72 (13) 5 (10)
Child’s sex—female 295 (47) 270 (47) 25 (51) .66
a

Children were classified as having a filaggrin mutation if they had a non-wildtype genotype for any of the following filaggrin mutation variants: R501X, S3247X, R2447X, 2282del4, p.S3316X, and p.R826X.

b

Group differences were assessed using the nonparametric Wilcoxon rank-sum tests.

c

Group differences were assessed using the Fisher’s exact tests.

d

Other race/ethnicity includes Asian, American Indian/Alaska Native, Hawaiian/Pacific Islander, and multiracial.